Cleared Traditional

K133491 - ADVIA CENTAUR TESTOSTERONE (TSTO) (FDA 510(k) Clearance)

Feb 2014
Decision
100d
Days
Class 1
Risk

K133491 is an FDA 510(k) clearance for the ADVIA CENTAUR TESTOSTERONE (TSTO). This device is classified as a Radioimmunoassay, Testosterones And Dihydrotestosterone (Class I - General Controls, product code CDZ).

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on February 21, 2014, 100 days after receiving the submission on November 13, 2013.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1680.

Submission Details

510(k) Number K133491 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 2013
Decision Date February 21, 2014
Days to Decision 100 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CDZ — Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1680